Gillian Dekkers

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Anti-capsid nanobodies function as HIV-1 capsid inhibitors by intracellular capsid degradation.

Anti-capsid nanobodies function as HIV-1 capsid inhibitors by intracellular capsid degradation.

Journal: Communications biology

Published: September 11, 2025

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Journal: iScience

Published: April 29, 2024

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.

Journal: Frontiers in immunology

Published: November 07, 2022

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.

Journal: Frontiers in immunology

Published: March 10, 2022

Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors.

Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors.

Journal: Frontiers in immunology

Published: August 06, 2021

Author Correction: Human DC-SIGN and CD23 do not interact with human IgG.

Author Correction: Human DC-SIGN and CD23 do not interact with human IgG.

Journal: Scientific reports

Published: July 25, 2020

IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice.

IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice.

Journal: Frontiers in immunology

Published: April 28, 2020

Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants.

Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H Variants.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: April 03, 2020

Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.

Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 14, 2019

Human DC-SIGN and CD23 do not interact with human IgG.

Human DC-SIGN and CD23 do not interact with human IgG.

Journal: Scientific reports

Published: December 18, 2018

IgG Glyco-Engineering to Improve IVIg Potency.

IgG Glyco-Engineering to Improve IVIg Potency.

Journal: Frontiers in immunology

Published: May 04, 2018

Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.

Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.

Journal: Rheumatology (Oxford, England)

Published: February 27, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026